Current adoptive immunotherapy in non-small cell lung cancer and potential influence of therapy outcome.
about
Development of PD-1/PD-L1 Pathway in Tumor Immune Microenvironment and Treatment for Non-Small Cell Lung CancerProgress in immunotherapy for non-small cell lung cancerAdvances of immunotherapy in small cell lung cancerInterferon induced transmembrane protein 3 regulates the growth and invasion of human lung adenocarcinoma.Clinical significance of serum T helper 1/T helper 2 cytokine shift in patients with non-small cell lung cancer.Intratumor IL-17-positive mast cells are the major source of the IL-17 that is predictive of survival in gastric cancer patients.Effectiveness and safety of chemotherapy combined with dendritic cells co-cultured with cytokine-induced killer cells in the treatment of advanced non-small-cell lung cancer: a systematic review and meta-analysis.Effectiveness of immune therapy combined with chemotherapy on the immune function and recurrence rate of cervical cancer.Meta-analysis of chemotherapy and dendritic cells with cytokine-induced killer cells in the treatment of non-small-cell lung cancerPreclinical data on the combination of cisplatin and anti-CD70 therapy in non-small cell lung cancer as an excellent match in the era of combination therapy.Programmed cell death-ligand 1 (PD-L1) expression and fibroblast growth factor receptor 1 (FGFR1) amplification in stage III/IV lung squamous cell carcinoma (SQC).Antiangiogenic therapy improves the antitumor effect of adoptive cell immunotherapy by normalizing tumor vasculature.Beyond chemotherapy and targeted therapy: adoptive cellular therapy in non-small cell lung cancer.Immune Therapy.Effects of a gemcitabine plus platinum regimen combined with a dendritic cell-cytokine induced killer immunotherapy on recurrence and survival rate of non-small cell lung cancer patients.Metformin inhibits lung cancer cells proliferation through repressing microRNA-222.CHAF1A, the largest subunit of the chromatin assembly factor 1 complex, regulates the growth of H1299 human non-small cell lung cancer cells by inducing G0/G1 cell cycle arrest.[Advances in immunotherapies for non-small cell lung cancer].
P2860
Q26798047-12158D53-0C75-4801-AF0B-C0D8ACF83D25Q26865725-2CFBC240-72DD-4CAE-BF1F-C9DA6618AFA2Q27027662-CA564133-5B76-4C19-B6AC-BFABE834E311Q33863411-5830880D-E5FA-4517-A117-A500DBCE4292Q34141885-AD7C2C0F-5EAB-4031-AE69-D04414EE1DB4Q34149842-C8ABFB46-364E-41D5-A771-305540007E17Q34277777-4D1CB6C3-25DF-4195-BDC2-E788456FF727Q35048698-6B34A711-B9F4-4B0A-A82B-2E9178D00992Q36183714-9202A1E7-AB1F-4858-80E2-14C230E81A1AQ36396832-C5ABDFF5-DC65-47AC-9C1B-C3308883EDFDQ37677845-DAF213DD-28CD-4205-BA4F-A1AE39BA507EQ38132055-6386B2A9-06E3-4691-9A74-D4B9B9399732Q38223594-198F4F28-B82F-4549-A120-D4E1F88AB2FFQ38669273-C31F140E-6A95-4C8F-B811-049522A05E3AQ38825476-85BEC5CB-633D-4DC3-8FDA-37CDBF36A8F3Q39105491-4CE54FA3-C486-4E7B-9FB6-90924F0AD69FQ47144485-90B11A43-60A8-4961-9D41-ED57AA76965EQ55441788-4C0ABA83-BDD1-4AF3-8A0E-1B0CBF541C02
P2860
Current adoptive immunotherapy in non-small cell lung cancer and potential influence of therapy outcome.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Current adoptive immunotherapy ...... influence of therapy outcome.
@en
type
label
Current adoptive immunotherapy ...... influence of therapy outcome.
@en
prefLabel
Current adoptive immunotherapy ...... influence of therapy outcome.
@en
P2093
P2860
P1433
P1476
Current adoptive immunotherapy ...... influence of therapy outcome.
@en
P2093
Run-Mei Li
Xin-Wei Zhang
Xiu-Bao Ren
Ya-Wen Zheng
P2860
P304
P356
10.3109/07357907.2013.775294
P577
2013-03-01T00:00:00Z